Boao International Medical Center
| Cina | Turchia | Austria | |
| Trapianto renale | da $68,500 | da $22,500 | da $95,000 |
| Trapianto di capelli | da $3,200 | da $2,300 | da $5,000 |
| Terapia con cellule staminali | da $11,500 | da $7,650 | da $8,500 |
| Rinoplastica | da $4,800 | da $3,487 | da $7,000 |
| Riduzione mammaria | da $5,800 | da $3,200 | da $7,500 |
Dr. Li Yanwen is an early leader in functional neurosurgery in China. He is a founder of neurosurgical navigation in the country. He is a Visiting Professor at the University of Turin. His awards include the First Prize of the Shenzhen Science and Technology Progress Award and the Third Prize of the Guangdong Provincial Science and Technology Progress Award.
He specializes in stereotactic and functional neurosurgery. He has over 20 years of experience and has completed more than 10,000 surgical localization procedures for Parkinson’s disease, cerebral palsy, and epilepsy. He is skilled in stereotactic and navigation techniques. His focus includes precision treatment for hard-to-treat cerebral hemorrhage and traumatic brain injury, post-stroke paralysis, Parkinson’s disease, Alzheimer’s disease, and spinal cord injury. He also performs targeted surgery for autism. He studies stem-cell therapies for neurological and autoimmune diseases.
Dr. Luan Tianyan, MD, is Head of Oncology. He was recruited to Hainan Province as a high-level talent. He is a visiting scholar at the Dana-Farber Cancer Institute (USA). He is also Director of the Clinical Research Office at Bozheng Hengda International Hospital. He serves on the standing committees of the Clinical Research Management Committee (Southern Oncology Clinical Research Association), the Immunotherapy Committee (Hainan Provincial Anti-Cancer Association), and the Hainan Province Drug Research Committee.
He has more than 20 years of oncology practice. He provides individualized, comprehensive care for gastrointestinal tumors, lung cancer, and breast cancer. He focuses on pain management, palliative care, and psychological support in advanced cancer. He also works on the clinical use and study of tumor immunotherapy, including personalized mRNA vaccines and CAR-T therapy. He develops and applies proprietary drugs and related technologies.
Il Dr. Chen Binglai è un esperto di immunologia biologica (MD). Ha conseguito un dottorato in Medicina presso la Central South University, con particolare attenzione alla genetica e all'integrazione della medicina tradizionale cinese e occidentale. Ha completato la formazione post-dottorato presso la New York University e l'Università di Bologna. È professore ospite presso l'Ospedale Zhongshan dell'Università Fudan.
È affiliato al programma di talenti Shanghai Pujiang e al programma di talenti 3310 del distretto di Yangpu. Guida il progetto di innovazione "Trattamento del cancro basato sulla tecnologia di coltura cellulare", sostenuto dal programma Pujiang.
Ha anni di pratica oncologica e una vasta esperienza nel trattamento dei tumori maligni. Il suo lavoro si concentra sull'uso clinico e sulla ricerca di terapie CAR-T, cellule NK e cellule staminali. Utilizza il programma pilota di Lecheng per far avanzare la traslazione clinica in Cina e offrire piani di trattamento personalizzati.
Scritto da Mariia Mytrofankina
Scritto da Mariia Mytrofankina
Scritto da Kateryna Zamkovska